首页> 外国专利> Use of early lung adenocarcinoma malignancy diagnostic markers focusing on epithelial-mesenchymal transition

Use of early lung adenocarcinoma malignancy diagnostic markers focusing on epithelial-mesenchymal transition

机译:早期肺腺癌恶性诊断标志物的应用,侧重于上皮-间质转化

摘要

PROBLEM TO BE SOLVED: To provide an inspection method using a malignancy diagnostic marker which is effective in predicting relapse/metastasis of early-stage pulmonary adenocarcinoma, and a kit thereof.SOLUTION: A method for inspecting malignancy of early-stage pulmonary adenocarcinoma regarding a sample derived from a subject includes detecting phosphorylation of at least one portion selected from a group consisting of 516-th tyrosine of TrkC, 1404-th tyrosine of TNS1, and 92-nd serine of SSFA2. An inspection kit of early-stage pulmonary adenocarcinoma includes at least one reagent selected from a group consisting of a reagent by which phosphorylation of 516-th tyrosine of TrkC can be detected, a reagent by which phosphorylation of 1404-th tyrosine of TNS1 can be detected, and a reagent by which phosphorylation of 92-nd serine of SSFA2 can be detected. There are also provided an antibody and a peptide.SELECTED DRAWING: Figure 5
机译:解决的问题:提供一种使用恶性诊断标志物的检查方法及其试剂盒,该检查方法可有效地预测早期肺腺癌的复发/转移及其试剂盒。解决方案:一种用于检查早期肺腺癌恶性程度的方法来自受试者的样品包括检测选自TrkC的516位酪氨酸,TNS1的1404位酪氨酸和SSFA2的92位丝氨酸的至少一部分的磷酸化。早期肺腺癌检查试剂盒包括选自可检测TrkC的516位酪氨酸磷酸化的试剂,可检测TNS1的1404位酪氨酸磷酸化的试剂中的至少一种试剂。检测到的试剂,以及可以检测到SSFA2的92位丝氨酸磷酸化的试剂。还提供了抗体和肽。选图:图5

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号